111 related articles for article (PubMed ID: 6658460)
21. [Blood coagulation-fibrinolysis tests by a biochemical method].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1993 Jul; 41(7):743-9. PubMed ID: 8361043
[TBL] [Abstract][Full Text] [Related]
22. Newer avenues in the monitoring of antithrombotic therapy: the role of automation.
Walenga JM; Fareed J; Messmore HL
Semin Thromb Hemost; 1983 Oct; 9(4):346-54. PubMed ID: 6658465
[TBL] [Abstract][Full Text] [Related]
23. [Blood coagulation analyzer].
Dobrovol'skiĭ NA; Kostritso PR; Labinskaia TA; Makarov VV; Parfenov AS; Peshkov AV
Med Tekh; 1999; (1):40-2. PubMed ID: 10198897
[TBL] [Abstract][Full Text] [Related]
24. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
Bohner J; von Pape KW; Blaurock M
Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
[TBL] [Abstract][Full Text] [Related]
25. [Comparative evaluation of 3 methods of study of antithrombin III].
Nakabanda A; Katsadze IuL; Kotovshchikova MA
Lab Delo; 1984; (5):276-9. PubMed ID: 6204109
[No Abstract] [Full Text] [Related]
26. [Clinical evaluations of antithrombin III and alpha 2-plasmin inhibitor assay method with chromogenic substrates (S-2238, S-2251 (author's transl)].
Fukuda C; Iijima K; Nakamura K
Rinsho Byori; 1981 Feb; 29(2):179-82. PubMed ID: 6453246
[No Abstract] [Full Text] [Related]
27. [Effects of methods of freezing and thawing of blood plasma on the activity of procoagulants and antithrombin-III].
Baryshev BA; Selivanov EA; Kobilianskaia VI; Andozhskaia IV; Kurenkova VV; Papaian LP
Vestn Khir Im I I Grek; 2000; 159(6):55-6. PubMed ID: 11209233
[TBL] [Abstract][Full Text] [Related]
28. False low antithrombin III results in renal disease.
Fisher AH
Med Lab Sci; 1985 Jan; 42(1):44-7. PubMed ID: 3982246
[No Abstract] [Full Text] [Related]
29. [At II in liver diseases. Comparison between immunological determination and that with chromogenic substrate].
Carmignoto F; Schivo P; Zotti S; Ceriotti G
Arch Sci Med (Torino); 1980; 137(3):467-70. PubMed ID: 6786256
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
Dorn-Beineke A; Dempfle CE; Bertsch T; Wisser H
Thromb Res; 2005; 116(2):171-9. PubMed ID: 15907533
[TBL] [Abstract][Full Text] [Related]
31. False assignment of familial antithrombin III deficiency with the von Kaulla assay.
Cosgriff TM; Hershgold EJ; Martin BA; Carlson KS
Am J Clin Pathol; 1983 Nov; 80(5):697-9. PubMed ID: 6416053
[TBL] [Abstract][Full Text] [Related]
32. [Clinical importance of the determination of antithrombin III by the use of a chromogenic substrate, in cases of disseminated intravascular coagulation and of acute hepatic insufficiency].
Carmignoto F; Schivo P; Plebani M; Pengo V; Piccini P; Ceriotti G
Quad Sclavo Diagn; 1981 Jun; 17(2):172-81. PubMed ID: 7267980
[TBL] [Abstract][Full Text] [Related]
33. Chromogenic peptide substrate assays in patients with multiple trauma.
Kierulf P; Aasen AO; Aune S; Godal HC; Ruud TE; Vaage J
Acta Chir Scand Suppl; 1982; 509():69-72. PubMed ID: 6962622
[TBL] [Abstract][Full Text] [Related]
34. [Antithrombin III: the correlation structure-function in healthy people and in cirrhotic patients (author's transl)].
Vicente JM; Díaz Cremades JM; Borrell M; Felez J; Gimferrer E; Pujol N; Domingo A; Rutllant ML
Sangre (Barc); 1978; 23(5):544-53. PubMed ID: 368998
[No Abstract] [Full Text] [Related]
35. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
Frantzen Handeland G; Abildgaard U; Aasen AO
Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
[TBL] [Abstract][Full Text] [Related]
36. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
[TBL] [Abstract][Full Text] [Related]
37. [Initial evaluation of the ACL-Futura coagulation analyzer].
Aulesa C; Petit M; Sentis M; Ortega JJ
Sangre (Barc); 1996 Dec; 41(6):417-26. PubMed ID: 9148419
[TBL] [Abstract][Full Text] [Related]
38. [On the determination of plasma antithrombin III with chromogenic peptide substrate (author's transl)].
Nakamura S; Takizawa N; Nakanishi K; Igarashi M
Rinsho Byori; 1980 Jan; 28(1):81-6. PubMed ID: 7373880
[No Abstract] [Full Text] [Related]
39. Anti-thrombin III levels in some Malaysian patients suspected of having acquired coagulation disorders.
Tan SH; Doraisamy G; Noriah R; Lopez CG
Singapore Med J; 1983 Feb; 24(1):33-6. PubMed ID: 6867763
[No Abstract] [Full Text] [Related]
40. [Evaluation of two-stage antithrombin III assay using new chromogenic peptide substrates (author's transl)].
Asai K; Takagi A; Otsubo M
Rinsho Byori; 1980 Jan; 28(1):76-80. PubMed ID: 7373879
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
